195 related articles for article (PubMed ID: 17538189)
1. Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade.
Takahashi H; Ichihara A; Kaneshiro Y; Inomata K; Sakoda M; Takemitsu T; Nishiyama A; Itoh H
J Am Soc Nephrol; 2007 Jul; 18(7):2054-61. PubMed ID: 17538189
[TBL] [Abstract][Full Text] [Related]
2. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice.
Ichihara A; Suzuki F; Nakagawa T; Kaneshiro Y; Takemitsu T; Sakoda M; Nabi AH; Nishiyama A; Sugaya T; Hayashi M; Inagami T
J Am Soc Nephrol; 2006 Jul; 17(7):1950-61. PubMed ID: 16738017
[TBL] [Abstract][Full Text] [Related]
3. Activated prorenin as a therapeutic target for diabetic nephropathy.
Ichihara A; Sakoda M; Mito-Kurauchi A; Itoh H
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S63-6. PubMed ID: 18922597
[TBL] [Abstract][Full Text] [Related]
4. (Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation.
Matavelli LC; Huang J; Siragy HM
Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):277-82. PubMed ID: 19769609
[TBL] [Abstract][Full Text] [Related]
5. Deterioration of kidney function by the (pro)renin receptor blocker handle region peptide in aliskiren-treated diabetic transgenic (mRen2)27 rats.
te Riet L; van den Heuvel M; Peutz-Kootstra CJ; van Esch JH; van Veghel R; Garrelds IM; Musterd-Bhaggoe U; Bouhuizen AM; Leijten FP; Danser AH; Batenburg WW
Am J Physiol Renal Physiol; 2014 May; 306(10):F1179-89. PubMed ID: 24694588
[TBL] [Abstract][Full Text] [Related]
6. (Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation.
Satofuka S; Ichihara A; Nagai N; Noda K; Ozawa Y; Fukamizu A; Tsubota K; Itoh H; Oike Y; Ishida S
Diabetes; 2009 Jul; 58(7):1625-33. PubMed ID: 19389828
[TBL] [Abstract][Full Text] [Related]
7. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats.
Feldman DL; Jin L; Xuan H; Contrepas A; Zhou Y; Webb RL; Mueller DN; Feldt S; Cumin F; Maniara W; Persohn E; Schuetz H; Jan Danser AH; Nguyen G
Hypertension; 2008 Jul; 52(1):130-6. PubMed ID: 18490518
[TBL] [Abstract][Full Text] [Related]
8. Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.
Batenburg WW; Verma A; Wang Y; Zhu P; van den Heuvel M; van Veghel R; Danser AH; Li Q
PLoS One; 2014; 9(6):e100954. PubMed ID: 24968134
[TBL] [Abstract][Full Text] [Related]
9. (Pro)renin receptor blocker improves survival of rats with sepsis.
Hirano Y; Takeuchi H; Suda K; Hagiwara T; Miyasho T; Kawamura Y; Yamada S; Oyama T; Takahashi T; Wada N; Saikawa Y; Ichihara A; Kitagawa Y
J Surg Res; 2014 Jan; 186(1):269-77. PubMed ID: 24011922
[TBL] [Abstract][Full Text] [Related]
10. Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.
Jacobsen P; Rossing K; Parving HH
Curr Opin Nephrol Hypertens; 2004 May; 13(3):319-24. PubMed ID: 15073491
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Combined Treatment with the (Pro)Renin Receptor Blocker HRP and Quinapril in Type 1 Diabetic Rats.
Kökény G; Fang L; Révész C; Mózes MM; Vörös P; Szénási G; Rosivall L
Kidney Blood Press Res; 2017; 42(1):109-122. PubMed ID: 28359068
[TBL] [Abstract][Full Text] [Related]
12. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats.
Kaneshiro Y; Ichihara A; Sakoda M; Takemitsu T; Nabi AH; Uddin MN; Nakagawa T; Nishiyama A; Suzuki F; Inagami T; Itoh H
J Am Soc Nephrol; 2007 Jun; 18(6):1789-95. PubMed ID: 17494887
[TBL] [Abstract][Full Text] [Related]
13. Add-on blockade of (pro)renin receptor in imidapril-treated diabetic SHRsp.
Seki Y; Ichihara A; Mizuguchi Y; Sakoda M; Kurauchi-Mito A; Narita T; Kinouchi K; Bokuda K; Itoh H
Front Biosci (Elite Ed); 2010 Jun; 2(3):972-9. PubMed ID: 20515768
[TBL] [Abstract][Full Text] [Related]
14. Renin, prorenin and the kidney: a new chapter in an old saga.
Ichihara A; Sakoda M; Kurauchi-Mito A; Kaneshiro Y; Itoh H
J Nephrol; 2009; 22(3):306-11. PubMed ID: 19557706
[TBL] [Abstract][Full Text] [Related]
15. Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.
Wilkinson-Berka JL; Gibbs NJ; Cooper ME; Skinner SL; Kelly DJ
Nephrol Dial Transplant; 2001 Jul; 16(7):1343-9. PubMed ID: 11427623
[TBL] [Abstract][Full Text] [Related]
16. What is the role of renin inhibition in the treatment of diabetic kidney disease?
Komers R
Curr Diab Rep; 2009 Dec; 9(6):447-52. PubMed ID: 19954690
[TBL] [Abstract][Full Text] [Related]
17. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
[TBL] [Abstract][Full Text] [Related]
18. Increased cyclooxygenase-2, hyperfiltration, glomerulosclerosis, and diabetic nephropathy: put the blame on the (pro)renin receptor?
Nguyen G
Kidney Int; 2006 Aug; 70(4):618-20. PubMed ID: 16900219
[TBL] [Abstract][Full Text] [Related]
19. The (pro)renin receptor blocker handle region peptide upregulates endothelium-derived contractile factors in aliskiren-treated diabetic transgenic (mREN2)27 rats.
Batenburg WW; van den Heuvel M; van Esch JH; van Veghel R; Garrelds IM; Leijten F; Danser AH
J Hypertens; 2013 Feb; 31(2):292-302. PubMed ID: 23303354
[TBL] [Abstract][Full Text] [Related]
20. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
